Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antibody-Based Targeted Interventions for the Diagnosis and Treatment of Skin Cancers.
Madheswaran S, Mungra N, Biteghe FAN, De la Croix Ndong J, Arowolo AT, Adeola HA, Ramamurthy D, Naran K, Khumalo NP, Barth S. Madheswaran S, et al. Among authors: naran k. Anticancer Agents Med Chem. 2021;21(2):162-186. doi: 10.2174/1871520620666200728123006. Anticancer Agents Med Chem. 2021. PMID: 32723261 Review.
Click Chemistry-Generated Auristatin F-Linker-Benzylguanine for a SNAP-Tag-Based Recombinant Antibody-Drug Conjugate Demonstrating Selective Cytotoxicity toward EGFR-Overexpressing Tumor Cells.
Huysamen AM, Fadeyi OE, Mayuni G, Dogbey DM, Mungra N, Biteghe FAN, Hardcastle N, Ramamurthy D, Akinrinmade OA, Naran K, Cooper S, Lang D, Richter W, Hunter R, Barth S. Huysamen AM, et al. Among authors: naran k. ACS Omega. 2023 Jan 17;8(4):4026-4037. doi: 10.1021/acsomega.2c06844. eCollection 2023 Jan 31. ACS Omega. 2023. PMID: 36743041 Free PMC article.
A recombinant Der p 1-specific allergen-toxin demonstrates superior killing of allergen-reactive IgG+ hybridomas in comparison to its recombinant allergen-drug conjugate.
Daramola AK, Akinrinmade OA, Fajemisin EA, Naran K, Mthembu N, Hadebe S, Brombacher F, Huysamen AM, Fadeyi OE, Hunter R, Barth S. Daramola AK, et al. Among authors: naran k. Immunother Adv. 2022 Dec 6;3(1):ltac023. doi: 10.1093/immadv/ltac023. eCollection 2023. Immunother Adv. 2022. PMID: 36789295 Free PMC article.
CSPG4 as a target for the specific killing of triple-negative breast cancer cells by a recombinant SNAP-tag-based antibody-auristatin F drug conjugate.
Mungra N, Biteghe FAN, Malindi Z, Huysamen AM, Karaan M, Hardcastle NS, Bunjun R, Chetty S, Naran K, Lang D, Richter W, Hunter R, Barth S. Mungra N, et al. Among authors: naran k. J Cancer Res Clin Oncol. 2023 Oct;149(13):12203-12225. doi: 10.1007/s00432-023-05031-3. Epub 2023 Jul 11. J Cancer Res Clin Oncol. 2023. PMID: 37432459 Free PMC article.
21 results